论文部分内容阅读
目的:探讨恶性肿瘤患者体内凝血状态。方法:对65例恶性肿瘤患者于治疗前进行血栓弹力图(TEG)及常现凝血象的检测。结果:恶性肿瘤患者TEG大多数表现为高凝图象:γ值、K值、M值明显缩短,均值分别为2.80±0.81(分)、1.10±0.30(分)、26.40±5.98(分)。Ma值明显增宽,均值为66.42±8.11(mm)。少部分晚期肿瘤患者TEG表现为低凝图象:γ值、K值、M值明显延长,均值分别为8.88±1.51(分)、5.63±1.33(分)、38.89±6.95(分)。Ma值明显变窄,均值为46.08±4.85(mm)。结论:恶性肿瘤患者体内存在凝血功能异常,临床可根据TEG的改变来判断恶性肿瘤患者临床所处凝血状态,正确指导治疗。
Objective: To investigate the coagulation status in patients with malignant tumors. Methods: A total of 65 patients with malignant tumors were tested for thromboelastogram (TEG) and regular coagulation before treatment. RESULTS: Most of the TEGs in patients with malignant tumors showed high coagulation images: γ value, K value, and M value were significantly shortened, with mean values of 2.80±0.81 (min) and 1.10±0.30 (min), respectively. 26.40±5.98 (in minutes). The Ma value was significantly broadened with an average value of 66.42±8.11 (mm). In a few patients with advanced stage tumors, TEG showed hypocoagulation: gamma, K, and M values were significantly prolonged. The mean values were 8.88±1.51 (min), 5.63±1.33 (min), respectively. .89±6.95 (in minutes). The Ma value was significantly narrowed with an average of 46.08±4.85 (mm). Conclusion: There is abnormal coagulation function in patients with malignant tumors. Clinically, the clinical coagulation status of patients with malignant tumors can be judged according to the changes of TEG, and the treatment can be guided correctly.